PPRX-1701, a nanoparticle formulation of 6′-bromoindirubin acetoxime, improves delivery and shows efficacy in preclinical GBM models
Mykola Zdioruk(Brigham and Women's Hospital), Sean Lawler(Brigham and Women's Hospital)
Cited by 13
Related Papers
Immune evasion mediated by PD-L1 on glioblastoma-derived extracellular vesicles
|Science Advances|2018|614
Blood-brain-barrier spheroids as an in vitro screening platform for brain-penetrating agents
|Nature Communications|2017|332
Extracellular Vesicles Modulate the Glioblastoma Microenvironment via a Tumor Suppression Signaling Network Directed by miR-1
|Cancer Research|2013|233
Cytomegalovirus promotes murine glioblastoma growth via pericyte recruitment and angiogenesis
|Journal of Clinical Investigation|2019|75
A Pt(IV)-conjugated brain penetrant macrocyclic peptide shows pre-clinical efficacy in glioblastoma
|Journal of Controlled Release|2022|27